
1. int j tuberc lung dis. 2012 sep;16(9):1180-5. doi: 10.5588/ijtld.12.0010. epub
2012 jul 12.

(18)f-fdg pet/ct tuberculosis: early non-invasive marker therapeutic
response.

martinez v(1), castilla-lievre ma, guillet-caruba c, grenier g, fior r, desarnaud
s, doucet-populaire f, boué f.

author information: 
(1)service de médecine interne et immunologie clinique, unité mixte de recherche 
en santé 996, institut national de la santé et de la recherche médicale, paris,
france. valerie.martinez@abc.aphp.fr

objective: evaluate potential (18)f-fluoro-deoxyglucose positron
emission tomography/computed tomography ((18)f-fdg pet/ct) early therapeutic 
intervention patients probable confirmed tuberculosis (tb).
methods: twenty-one consecutive human immunodeficiency virus negative patients
were prospectively included. patients underwent (18)f-fdg pet/ct and
after 1 month anti-tuberculosis treatment. maximum standardised uptake
value (suv(max)) (18)f-fdg avid lesions recorded.
results: median age patients 36 years (range 18-84); 33.3% male, 
80.9% born endemic countries, 23.8% past history tb. tb 
confirmed culture 8, histology 9 basis clinical
symptoms 4 patients. (18)f-fdg pet/ct detected active pulmonary tb (n = 1),
extra-pulmonary (n = 10) (n = 10). second (18)f-fdg pet/ct showed
reduced radiotracer uptake intensity 19 21 patients, median
percentage decrease suv(max) 31% (range 2-84). two patients showed no
improvement. tb ruled one patient follow-up; final
diagnosis non-hodgkin's lymphoma. patient smear-positive 
3 months.
conclusion: (18)f-fdg pet/ct allows easy evaluation early therapeutic
response patients tb, particularly extra-pulmonary tb.

doi: 10.5588/ijtld.12.0010 
pmid: 22794271  [indexed medline]

